According to a study in JAMA, adding thrombolytics to conventional approaches when treating patients with sudden-onset pulmonary embolism is associated with 47% fewer deaths than using standard anticoagulant medications alone. Read more and read the study abstract.
Study: Thrombolytics significantly reduce mortality in sudden-onset PE
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
